EHA 2022: Effects of Luspatercept on Need for Red Blood Cell Transfusions are Sustained in Patients with β-Thalassemia
Update from BELIEVE has now followed patients beyond 3 years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.